Incidence, management, and outcome of high-grade transformation of nodular lymphocyte predominant hodgkin lymphoma: Long-term outcomes from a 30-year experience

被引:29
作者
Eyre, Toby A. [1 ]
Gatter, Kevin [2 ]
Collins, Graham P. [1 ]
Hall, Georgina W. [3 ]
Watson, Caroline [1 ]
Hatton, Chris S. R. [1 ]
机构
[1] Oxford Univ Hosp NHS Trust, Dept Haematol, Oxford OX3 7LE, England
[2] Oxford Univ Hosp NHS Trust, Nuffield Div Clin Lab Sci, Oxford OX3 7LE, England
[3] Oxford Univ Hosp NHS Trust, John Radcliffe Hosp, Childrens Hosp, Paediat Haematol & Oncol Unit, Oxford OX3 7LE, England
关键词
B-CELL LYMPHOMA; CLINICAL PRESENTATION; FOLLOW-UP; DISEASE; CHILDREN; STAGE; RITUXIMAB; ONCOLOGY; CANCER; CHEMOTHERAPY;
D O I
10.1002/ajh.23989
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Nodular lymphocyte predominant Hodgkin lymphoma (NLPHL) is a rare form of Hodgkin lymphoma that typically presents as early stage, indolent disease in young adult males. The relationship between NLPHL and DLBCL is incompletely understood, and there remains a paucity of data with regard the incidence and management of high-grade transformation. We report the largest study to date describing the incidence, management and long-term outcome of 26 cases of high-grade transformation of NLPHL over a 30-year period. We report a transformation incidence of 17.0%. Bone marrow, splenic, and liver infiltration with DLBCL was frequent. Patients with an aa-IPI 2-3 have poorer OS and PFS (P=0.034 and P=0.009, respectively). Although the approach to treatment was somewhat variable, typically young, otherwise fit patients received anthracycline-based induction, platinum-based consolidation with stem cell harvesting, followed by autologous SCT with BEAM conditioning. Long-term (5 year) PFS was over 60% with this approach, and comparable to our de novo DLBCL historical age and time period-matched cohort largely treated with CHOP-like chemotherapy alone. The transformation rate of 17.0% highlights the importance of accurate initial diagnosis, long-term follow-up, and re-biopsy at relapse. Am. J. Hematol. 90:E103-E110, 2015. (c) 2015 Wiley Periodicals, Inc.
引用
收藏
页码:E103 / E110
页数:8
相关论文
共 38 条
[1]  
Achten R, 2003, HAEMATOLOGICA, V88, P1431
[2]   Mature Results of a Phase II Study of Rituximab Therapy for Nodular Lymphocyte-Predominant Hodgkin Lymphoma [J].
Advani, Ranjana H. ;
Horning, Sandra J. ;
Hoppe, Richard T. ;
Daadi, Sarah ;
Allen, John ;
Natkunam, Yasodha ;
Bartlett, Nancy L. .
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (09) :912-+
[3]   Transformation to Aggressive Lymphoma in Nodular Lymphocyte-Predominant Hodgkin's Lymphoma [J].
Al-Mansour, Mubarak ;
Connors, Joseph M. ;
Gascoyne, Randy D. ;
Skinnider, Brian ;
Savage, Kerry J. .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (05) :793-799
[4]   Impact of low-dose involved-field radiation therapy on pediatric patients with lymphocyte-predominant Hodgkin lymphoma treated with chemotherapy: A report from the Children's Oncology Group [J].
Appel, Burton E. ;
Chen, Lu ;
Buxton, Allen ;
Wolden, Suzanne L. ;
Hodgson, David C. ;
Nachman, James B. .
PEDIATRIC BLOOD & CANCER, 2012, 59 (07) :1284-1289
[5]   NON-HODGKINS-LYMPHOMA ARISING IN PATIENTS TREATED FOR HODGKINS-DISEASE IN THE BNLI - A 20-YEAR EXPERIENCE [J].
BENNETT, MH ;
MACLENNAN, KA ;
HUDSON, GV ;
HUDSON, BV .
ANNALS OF ONCOLOGY, 1991, 2 :83-92
[6]   Nodular, Lymphocyte-Predominant Hodgkin Lymphoma A Long-Term Study and Analysis of Transformation to Diffuse Large B-Cell Lymphoma in a Cohort of 164 Patients From the Adult Lymphoma Study Group [J].
Biasoli, Irene ;
Stamatoullas, Aspasia ;
Meignin, Veronique ;
Delmer, Alain ;
Reman, Oumedaly ;
Morschhauser, Franck ;
Coiffier, Bertrand ;
Bosly, Andre ;
Divine, Marine ;
Brice, Pauline .
CANCER, 2010, 116 (03) :631-639
[7]   Clinical presentation and outcome in lymphocyte-predominant Hodgkin's disease [J].
Bodis, S ;
Kraus, MD ;
Pinkus, G ;
Silver, B ;
Kadin, ME ;
Canellos, GP ;
Shulman, LN ;
Tarbell, NJ ;
Mauch, PM .
JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (09) :3060-3066
[8]  
Borowitz MJ, 2017, WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, P199
[9]   Nodular lymphocyte-predominant Hodgkin lymphoma with nodules resembling T-cell/histiocyte-rich B-cell lymphoma:: differential diagnosis between nodular lymphocyte-predominant Hodgkin lymphoma and T-cell/histiocyte-rich B-cell lymphoma [J].
Boudová, L ;
Torlakovic, E ;
Delable, J ;
Reimer, P ;
Pfistner, B ;
Wiedenmann, S ;
Diehl, V ;
Müller-Hermelink, HK ;
Rüdiger, T .
BLOOD, 2003, 102 (10) :3753-3758
[10]   Early-Stage, Lymphocyte-Predominant Hodgkin's Lymphoma: Patient Outcomes From a Large, Single-Institution Series With Long Follow-Up [J].
Chen, Ronald C. ;
Chin, Michael S. ;
Ng, Andrea K. ;
Feng, Yang ;
Neuberg, Donna ;
Silver, Barbara ;
Pinkus, Geraldine S. ;
Stevenson, Mary Ann ;
Mauch, Peter M. .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (01) :136-141